Terns Pharmaceuticals, Inc. (TERN) Tops Q1 EPS by 4c

Terns Pharmaceuticals, Inc. (NASDAQ: TERN) reported Q1 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Terns Pharmaceuticals, Inc. (TERN) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• SpaceX (SPCX) call put ratio 1.5 calls to 1 put as share price up 1.4%
• Broadcom (AVGO) spreader of September 220 and 360 puts